Back to patient cases homepage You might also like Accessible only to healthcare professionals authorized to prescribe Clinical Case Study Compendium: Video case report 1 Real-World Experiences by Dr. A. de Voeght; Sart Tilman-CHU Liège Video of the 1st case report View more Accessible only to healthcare professionals authorized to prescribe Clinical Case Study Compendium: Video case report 2 Real-World Experiences by Dr. A. de Voeght; Sart Tilman-CHU Liège Video of the 2nd case report View more Article: The Role of Gilteritinib in the Treatment of Relapsed or Refractory FLT3-Mutated AML¹ PDF Part I: first 2 case reportsCase report 1: gilteritinib as salvage treatment post Venetoclax-AzacitidineCase report 2: gilteritinib as bridging therapy to allo HSCT2Intended for: practitioners hematologyWhy: up-to-date knowledge TKI3 related target therapyWhen: read nowLanguage: EnglishDuration: 10 minutes 1: Acute Myeloid Leukemia; 2: Hematopoietic Stem Cell Transplantation; 3: Tyrosine Kinase Inhibitor.MAT-BE-XOS-2025-00023 NOV 2025 Log in and read AML: Acute Myeloid LeukemiaCOPYRIGHT © 2026 ASTELLAS PHARMA B.V. MAT-BE-XOS-2025-00030 - DEC 2025